Endocrinology (all articles)
Open-label RCT | Moderate-intensity statin plus ezetimibe is noninferior to high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease.
20 Jul, 2022 | 12:32h | UTCLong-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
RCT | Efficacy and safety of once-weekly Efpeglenatide monotherapy versus placebo in Type 2 Diabetes.
19 Jul, 2022 | 13:20h | UTC
Review | Cardiometabolic comorbidities in cancer survivors.
19 Jul, 2022 | 13:17h | UTCCardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolemia.
18 Jul, 2022 | 11:18h | UTC
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).
18 Jul, 2022 | 11:09h | UTC
Cohort Study | Association of polycystic ovary syndrome with offspring morbidity.
18 Jul, 2022 | 10:58h | UTCAssociation of PCOS with offspring morbidity: a longitudinal cohort study – Human Endocrinology
Burden of diabetes and hyperglycemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
18 Jul, 2022 | 10:54h | UTC
Cohort Study | Risks of stroke and heart disease following hysterectomy and oophorectomy in premenopausal women.
15 Jul, 2022 | 13:07h | UTCCommentary: Removal of Uterus, Ovaries Poses Extra Cardiovascular Risk for Younger Women – MedPage Today (free registration required)
Guideline on prevention of foot ulceration in diabetic patients.
15 Jul, 2022 | 12:51h | UTCRelated:
Guideline: ADA 2022 Standards of Medical Care in Diabetes.
NICE Updated Guidance: Management of Type 2 Diabetes.
Recent updates to clinical practice guidelines for diabetes mellitus.
Nutrition and lifestyle recommendations for patients with gout and hyperuricemia.
13 Jul, 2022 | 11:37h | UTC
M-A | Dual-hormone artificial pancreas for glucose control in type 1 diabetes.
13 Jul, 2022 | 11:19h | UTC
ADA Guideline Summary | Obesity and weight management for prevention and treatment of Type 2 Diabetes.
12 Jul, 2022 | 13:06h | UTCObesity and Weight Management for Prevention and Treatment of Type 2 Diabetes – JAMA (free for a limited period)
Original Guideline: ADA 2022 Standards of Medical Care in Diabetes – American Diabetes Association
NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
12 Jul, 2022 | 12:48h | UTCCommentary: National Lipid Association Scientific Statement on Statin Intolerance – American College of Cardiology
Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages.
11 Jul, 2022 | 12:10h | UTCNews Release: Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages – Emory University
Original Study: Changes in the Incidence of Childhood Obesity – Pediatrics
M-A | Antithyroid drug therapy in pregnancy and risk of congenital anomalies.
8 Jul, 2022 | 11:36h | UTC
M-A | Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus.
8 Jul, 2022 | 11:25h | UTC
Post-hoc analysis | Can SGLT2 inhibitors reduce the risk of nephrolithiasis?
7 Jul, 2022 | 12:42h | UTC
Post-hoc analysis | Can SGLT2 inhibitors reduce the risk of hyperuricemia and gout?
7 Jul, 2022 | 12:40h | UTC
Guideline on the diagnosis and management of peripheral artery disease.
6 Jul, 2022 | 11:42h | UTCRelated:
Systematic Review | Long-term follow-up on morbidity among women with a history of gestational diabetes mellitus.
6 Jul, 2022 | 11:17h | UTCKey studies published in 2021 related to primary prevention of atherosclerotic cardiovascular disease.
5 Jul, 2022 | 12:12h | UTCHighlights in ASCVD Primary Prevention for 2021 – Journal of the American Heart Association
Delphi-Based Consensus | Practical guidance on basal insulin initiation and titration in Asia.
5 Jul, 2022 | 12:03h | UTCSafety of empagliflozin in patients with Type 2 Diabetes and chronic kidney disease: pooled analysis of placebo-controlled clinical trials.
1 Jul, 2022 | 10:44h | UTC
Secondary analysis of a RCT: Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes.
30 Jun, 2022 | 10:58h | UTCOriginal Study: Empagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine
M-A: Effect of divergent continuous glucose monitoring technologies on glycemic control in type 1 diabetes mellitus.
30 Jun, 2022 | 10:29h | UTC